Coronary biomarkers and long-term clinical outcome in acute coronary syndrome without ST segment elevation;Biomarcadores coronarios y evolución clínica alejada en pacientes con síndromes coronarios agudos sin elevación del segmento ST

Revista Medica de Chile

Volumn 133, Issue 11, 2005, Pages 1285-1293

  Baeza V, Ricardo ^a,b   Corbalán H, Ramón ^a   Castro G, Pablo ^a   Acevedo B, Mónica ^a   Quiroga G, Teresa ^a   Viviani G, Paola ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b Unidad Coronaria   (Chile)

Author keywords

Angina, unstable; C reactive protein; Coronary arteriosclerosis; Lipoprotein (a); P selectin

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CREATINE KINASE MB; LIPOPROTEIN A; PADGEM PROTEIN;

ACUTE DISEASE; ARTICLE; BLOOD; CORONARY ARTERY ATHEROSCLEROSIS; EPIDEMIOLOGY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; INFLAMMATION; MALE; MIDDLE AGED; MORTALITY; UNSTABLE ANGINA PECTORIS;

ACUTE DISEASE; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CORONARY ARTERIOSCLEROSIS; CREATINE KINASE, MB FORM; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INFLAMMATION; LIPOPROTEIN(A); MALE; MIDDLE AGED; P-SELECTIN;

EID: 31144446915     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. FUSTER V, BADIMON J, CHESEBRO JH, FALLON JT. Plaque rupture, thrombosis, and therapeutic implications. Haemostasis 1996; 26 Suppl 4: 269-84.
2. ROSS R. Atherosclerosis; an inflammatory disease. N Eng J Med 1999; 340: 115-26.
3. ISA R, CASTRO P, PÉREZ O, GARAYAR B, BAEZA R, VERGARA I ET AL. Hacia el desarrollo de una unidad de dolor torácico. Estudio Piloto. Rev Chil Cardio 2003; 22: 123.
4. CASAGRANDA I, BOVERIO R, BAIO R, CECCONI D, MARENCO M. Chest pain unit and decentralized testing of cardiac markers. Clin Chim Acta 2001; 311: 63-6.
5. STORROW AB, GIBLER WB. The role of cardiac markers in the emergency department. Clin Chim Acta 1999; 284: 187-96.
6. ANTMAN EM, COHEN M, BERNINK PJ, MCCABE CH, HORACEK T, PAPUCHIS G ET AL. The TIMI risk score for unstable angina/non ST elevation MI: A method for prognostication and therapeutic decision making. JAMA 2000; 284: 835-42.
7. HEESCHEN C, HAMM CW, BRUEMMER J, SIMOONS ML. Predictive value of C reactive protein and Troponin T in patients with unstable angina: a comparative analysis: CAPTURE Investigators. J Am Coll Cardiol 2000; 35: 1535-42.
8. MAZZONE A, DE SERVI S, RICEVUTI G, MAZZUCCHELLI I, FOSSATI G, PASOTTI D ET AL. Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease. Circulation 1993; 88: 358-63.
9. MULVIHILL N, FOLEY JB, MURPHY R, CREAN P, WALSH M. Evidence of prolonged inflammation in unstable angina and non Q wave myocardial infarction. J Am Coll Cardiol 2000; 36: 1210-5.
10. BIASUCCI LM, LIUZZO G, GRILLO RL, CALIGIURI G, REBUZZI AG, BUFFON A ET AL. Elevated levels of C reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 1999; 99: 855-60.
11. NATALI A, L'ABBATE A, FERRANNINI E. Erythrocyte sedimentation rate, coronary atherosclerosis and cardiac mortality. Eur Heart J 2003, 24: 639-48.
12. ERIKSSEN G, LIESTOL K, BJORNHOLT JV, STORMORKEN H, THAULOW E, ERIKSSEN J. Erythrocyte sedimentation rate: a possible marker of atherosclerosis and a strong predictor of coronary heart disease mortality. Eur Heart J 2000; 21: 1614-20.
13. BHOLASINGH R, CORNEL JH, KAMP O, VAN STRAALEN JP, SANDERS GT, DIJKSMAN L ET AL. The prognostic value of markers of inflammation in patients with troponin T-negative chest pain before discharge from the emergency department. Am J Med 2003; 115: 521-8.
14. DAVIES MJ. Stability and instability: two faces of coronary atherosclerosis. Circulation 1996; 94: 2013-20.
15. MARCOVINA SM, KOSCHINSKY ML. Lipoprotein (a) as a risk factor for coronary artery disease. Am J Cardiol 1998; 82: 57-66.
16. IGARASHI Y, AIZAWA Y, SATOH T, KONNO T, OJIMA K, AIZAWA Y. Predictors of adverse long-term outcome in acute myocardial infarction patients undergoing primary percutaneous transluminal coronary angioplasty: with special reference to the admission concentration of lipoprotein (a). Circ J 2003; 67: 605-11.
17. GAWAS M, REININGER A, NEUMANN FJ. Platelet Function and Platelet-Leukocyte Adhesion in Symptomatic Coronary Heart Disease. Effects of Intravenous Magnesium. Thromb Res 1996; 83: 341-9.
18. IKEDA H, TAKAJO Y, ICHIKI K, UENO T, MAKI S, NODA T ET AL. Increased soluble form of P Selectin in patients with unstable angina. Circulation 1995; 92: 1693-6.
19. HOLLANDER J, MUTTREJA R, DALESANDRO M, SHOFER F. Risk stratification of emergency department patients with acute coronary syndromes using P selectin. J Am Coll Cardiol 1999; 34: 95-105.
20. SARMA J, LAAN C, ALAM S, JHA A, FOX K, DRANSFIELD I. Increased platelet binding to circulating monocytes in acute coronary syndromes. Circulation 2002; 105: 2166-71.
21. SEREBRUANY VL, KEREIAKES DJ, DALESANDRO MR, GURBEL PA. The flowcitometer model markedly affects measurements of ex vivo whole blood platelet-bound P selectin expresion in patients with chest pain: are we comparing apples with oranges? Thromb Res 1999; 96: 52-6.
22. GURBEL PA, KEREIAKES DJ, SEREBRUANY VL. Soluble P selectin is not a surrogate marker for platelet P selectin, evidence from a multicenter chest pain study group. J Thromb Thrombolysis 2000; 10: 15-22.
23. FLEMING TR, DEMETS DL. Surrogate end points in clinical trials: are we being misled? Ann Intern Med 1996; 125: 605-13.